arterial remodeling technologies

Arterial Remodeling Technologies (“ART”) is developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. The Company’s technology is based on intellectual property originating from three esteemed institutions: the Cleveland Clinic; the French national research institute, C.N.R.S. (Centre National de Recherche Scientifique), Montpellier; and, Descartes University, Paris.

ART’s bioresorbable stents are designed to dismantle in vivo over an optimized time horizon, thus allowing the body’s own natural arterial remodeling process to occur, unrestricted by the presence of a permanent metallic stent. The Company’s proprietary, polymer-based technology promotes the natural remodeling of an injured and/or diseased artery after angioplasty or other similar procedures. ART has established proof-of-concept with preclinical implantation studies in iliac and coronary models that can be applied and adapted to a wide variety of stent designs.